If You Blow the Whistle, Are You Protected?

Nov. 3, 2005
The Sarbanes-Oxley Act has added a wrinkle to whistleblower protections first outlined in 1989. This exhaustive research by Harvard third-year law student John Rouse outlines protections for FDA and private-sector pharmaceutical employees, with a special look at the implications of Dr. David Graham’s criticism of FDA’s oversight of Vioxx.
About the Author

John Rouse | John Rouse